The impact of body mass index onshort- and long-term outcomes inpatients undergoing coronary revascularization insights from the bypass angioplasty revascularization investigation (BARI) by Gurm, Hitinder S et al.
The Impact of Body Mass Index on
Short- and Long-Term Outcomes in
Patients Undergoing Coronary Revascularization
Insights From the Bypass Angioplasty Revascularization Investigation (BARI)
Hitinder S. Gurm, MD,* Patrick L. Whitlow, MD, FACC,* Kevin E. Kip, PHD,† for the BARI
Investigators
Cleveland, Ohio and Pittsburgh, Pennsylvania
OBJECTIVES We sought to investigate the impact of body mass index (BMI) on short- and long-term
outcomes after initial revascularization with percutaneous transluminal coronary angioplasty
(PTCA) or coronary artery bypass graft surgery (CABG).
BACKGROUND Equivocal results exist on the impact of BMI on the risk of in-hospital complications after
PTCA or CABG, and no long-term mortality data exist from a large series of revascularized
patients.
METHODS From the randomized series and observational registry of the Bypass Angioplasty Revascu-
larization Investigation (BARI), 2,108 patients who had PTCA and 1,526 patients who had
CABG were evaluated by taking their BMI at study entry. They were classified as follows: low
(20 kg/m2), normal (20 to 24.9 kg/m2), overweight (25 to 29.9 kg/m2), class I obese (30 to
34.9 kg/m2) and class II/III obese (35 kg/m2). In-hospital complications and short- and
long-term mortalities were compared between levels of BMI within each mode of initial
revascularization.
RESULTS Among patients who had PTCA, each unit increase in BMI was associated with a 5.5% lower
adjusted risk of a major in-hospital event (death, myocardial infarction, stroke, coma); among
patients who had CABG, no difference in the in-hospital outcome was observed according to
BMI. In contrast, BMI was not associated with five-year mortality in the PTCA group;
among the CABG group, adjusted relative risks of five-year cardiac mortality according to
levels of BMI were 0.0 (low), 1.0 (normal), 2.02 (overweight), 3.16 (class I obese) and 4.85
(class II/III obese) (linear p  0.001).
CONCLUSIONS Body mass index appears to have a differential impact on short- and long-term outcomes after
coronary revascularization. These results underscore the need for further research to identify
factors responsible for the apparent short-term protective effect of a higher BMI in patients
undergoing PTCA and to study the impact of weight reduction on the long-term survival of
obese patients undergoing CABG. (J Am Coll Cardiol 2002;39:834–40) © 2002 by the
American College of Cardiology Foundation
Obesity is a common and growing problem; almost one-
third of American adults are obese (1). Annual health care
costs attributable to obesity have been estimated to be
approximately $68 billion, with an additional $30 billion
being spent on weight-reduction programs and special diets
(1). The relationship of obesity to long-term survival is
complex—most studies have found a J- or U-shaped curve
with increasing mortality in the very lean or very obese (2,3).
However, when the data have been adjusted for smoking
and concurrent illness, the relationship has been more
linear—the risk of death rises as body mass index (BMI)
increases (4,5). Body mass index is a validated measure of
adiposity (6) and has been consistently used in previous
analyses of obesity and mortality.
Cardiovascular disease is the leading cause of mortality in
the U.S. (7), and obese adults are at an increased risk of
cardiovascular mortality (8). In the past two decades, there
has been a great increase in the number of patients who
undergo coronary revascularization, with an estimated
607,000 coronary artery bypass graft surgeries (CABG) and
407,000 percutaneous coronary interventions (PCI) per-
formed in 1997 (7). Data from PCI registries suggest that
the very lean and the very obese have an increased risk of
in-hospital complications and short-term mortality (9). In
contrast, among patients undergoing CABG, most studies
have failed to identify an increased risk of mortality or
serious complications in obese patients (10–12). Collec-
tively, these studies have been valuable, but have been
limited by a general failure to account for important
confounding factors, including smoking and concurrent
illness. Furthermore, no long-term data are available on the
impact of BMI on survival in a large series of patients who
have undergone PCI or CABG.
Herein, we evaluate the impact of BMI on short- and
long-term outcomes in a large series of patients undergoing
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coronary revascularization enrolled in the Bypass Angio-
plasty Revascularization Investigation (BARI).
METHODS
The details and design of BARI have been published
elsewhere (13,14). Briefly, BARI is a multicenter trial
comparing CABG with percutaneous transluminal coronary
angioplasty (PTCA). Patients with clinically severe angina
or objective evidence of ischemia and angiographically
documented multivessel disease suitable for both CABG
and PTCA were eligible for enrollment. Patients with a
history of coronary revascularization, single-vessel coronary
artery disease or primary congenital, valvular or myocardial
disease and those 17 years or 80 years were excluded.
After obtaining written, informed patient consent, 1,829
patients were randomly assigned to undergo either initial
CABG or PTCA between August 1988 and August 1991.
Another 2,010 eligible patients who declined randomization
were also followed in the BARI observational registry. The
study was approved by the Institutional Review Board of the
University of Pittsburgh. The present report is based on
patients in both the randomized trial and the observational
registry who underwent initial revascularization (as defined
subsequently).
The initial revascularization was carried out within two
weeks of randomization for patients in the randomized trial
and within three months of enrollment for patients in the
observational registry. Patients in the observational registry
who did not undergo revascularization within three months
were considered to be “medically treated.” Staged PTCA
procedures were counted as a single procedure. The Core
Angiographic Laboratory at Stanford University Medical Cen-
ter (Stanford, California) interpreted the angiographic data
from patients in the randomized trial, but not from those in the
observational registry. Therefore, clinical site angiographic
readings were used for all patients. Balloon angioplasty was the
only percutaneous technique utilized in BARI, although at a
few sites, stenting was available as a bailout device for threat-
ened closure under a Food and Drug Administration investi-
gational protocol. Follow-up clinic visits were conducted at
weeks 4 through 14 and at 1, 3 and 5 years. Telephone contact
was made at 6 months and at 2 and 4 years. Complete
follow-up over 5 years was obtained in 99% of all patients.
Definitions and outcomes. Vital data were obtained for all
patients. A Q-wave myocardial infarction (MI) was defined
as a new pathologic Q-wave in two or more contiguous
leads, or as new left bundle branch block with twice the
normal level of total creatine kinase and an abnormal MB
isoenzyme level. A major in-hospital event was defined as
death, MI, stroke or coma. A cardiopulmonary event was
defined as congestive heart failure, pulmonary edema, hy-
potension requiring treatment, nonfatal cardiac arrest (re-
quiring direct current shock or cardiopulmonary resuscita-
tion), cardiogenic shock or respiratory failure requiring
re-intubation or intubation for more than 72 h. Emergency
revascularization was defined as emergency PTCA, emer-
gency PTCA with the use of another device or emergent
CABG. A local complication was defined as a peripheral
arterial embolus or the loss of a peripheral pulse requiring
treatment, re-operation for bleeding, wound dehiscence or
infection. Long-term mortality (three and five years) in-
cluded all-cause mortality and cardiac mortality, as deter-
mined by an independent Morbidity and Mortality Classi-
fication Committee.
Body mass index was calculated as weight in kilograms
divided by the square of height in meters (kg/m2). For the
purpose of our analysis, we divided the BMI into low
(20 kg/m2), normal (20 to 24.9 kg/m2) overweight (25 to
29.9 kg/m2), obese (30 to 34.9 kg/m2) and severely obese
(35 kg/m2).
Statistical analysis. Chi-square analysis and analysis of
variance were used to compare differences in baseline and
initial procedural characteristics between patients in the five
study-defined BMI groups. With the exception of baseline
clinical and angiographic characteristics, all analyses were
performed separately for PTCA and CABG patients. Crude
in-hospital event rates between the BMI groups were
compared by chi-square tests; long-term mortality rates
(all-cause and cardiac-only) were estimated by the Kaplan-
Meier method (15). Deaths due to noncardiac causes were
censored in determining cardiac mortality. Unadjusted and
adjusted odds ratios of in-hospital events according to the
level of BMI were estimated by use of logistic regression;
relative risks for long-term mortality were estimated by Cox
regression analysis (16). Statistical adjustment included
demographic and clinical factors that differed in prevalence
between the study-defined BMI groups and were associated
with at least one of the outcomes of interest. Both linear and
curvilinear effects were evaluated across the five BMI
groups. In the analysis of long-term mortality, initial in-
hospital deaths were excluded to assess the effect of BMI on
late outcomes. We chose to exclude in-hospital deaths,
because they are more likely to represent the outcome in the
more seriously ill patients and probably differ from late
mortality in terms of etiology. All analyses were performed
with the SAS System for Windows, version 8.01 (SAS
Institute, Cary, North Carolina).
RESULTS
Study group. A total of 3,634 patients underwent initial
revascularization and were available for analysis. Angio-
Abbreviations and Acronyms
BARI  Bypass Angioplasty Revascularization
Investigation
BMI  body mass index
CABG  coronary artery bypass graft surgery
MI  myocardial infarction
PCI  percutaneous coronary intervention
PTCA  percutaneous transluminal coronary angioplasty
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plasty patients included 919 from the randomized series and
1,189 from the observational registry; surgically treated
patients included 901 from the randomized series and 625
from the observational registry. According to the study-
defined BMI groups, in 64 patients (2%) the BMI was 20
kg/m2, in 867 (24%) it was 20 to 24.9 kg/m2, in 1,677 (46%)
it was 25 to 29.9 kg/m2, in 777 (21%) it was 30 to 34.9
kg/m2 and in 249 (7%) it was 35 kg/m2.
The characteristics of the patients at study entry differed
markedly in terms of initial BMI. Body mass index was
inversely associated with age, being a current smoker and a
history of cancer and was positively associated with a history
of treated diabetes, hypertension and previous evidence of
major Q-waves (Table 1). In addition, patients at the
extremes of BMI were more likely to be female and to have
a history of congestive heart failure and unstable angina.
Patients with a low BMI (20 kg/m2) were more likely to
have a history of renal dysfunction, and those at the highest
level of BMI (35 kg/m2) were least likely to be involved in
a regular exercise program at study entry (Table 1).
Initial procedural characteristics. Among the 2,108 pa-
tients who underwent initial PTCA, the number of in-
tended lesions and attempted lesions and procedural success
did not appreciably differ according to BMI (Table 2).
Similarly, among the 1,526 patients who had CABG, the
presence of calcified aorta, number of grafts placed and
ability to graft all intended vessels did not differ according to
BMI. However, there was a modest indication of less
frequent use of an internal mammary artery graft among
patients with BMI 25 kg/m2.
Table 1. Characteristics of Patients at Study Entry According to BMI (n  3,634)
Characteristic at Study Entry












Age 65 years (%) 41 41 35 31 26  0.001
Female gender (%) 50 28 21 28 43  0.001
Caucasian (%) 89 92 94 91 88 0.08
History of MI (%)* 61 53 53 52 50 0.60
History of treated diabetes (%) 11 11 15 26 38  0.001
History of hypertension (%)* 45 41 47 57 66  0.001
History of CHF (%)* 8 5 7 9 10 0.01
Unstable angina (%) 73 63 60 63 68 0.04
Major Q waves (%)* 11 15 18 21 22 0.005
Triple-vessel disease (%)* 36 38 39 38 36 0.88
LAD disease 50% (%)* 75 85 83 79 78 0.007
Significant lesions 70% (mean no.)* 1.7 1.7 1.7 1.8 1.8 0.13
One or more total occlusions (%)* 39 28 36 38 35 0.002
Ejection fraction (mean %)* 59 61 61 61 63 0.08
Peripheral vascular disease (%)* 11 8 8 6 6 0.15
Current smoker (%) 45 29 21 22 19  0.001
History of malignancy (%)* 11 5 5 5 3 0.17
History of renal dysfunction (%)* 8 2 2 3 1 0.01
Involved in regular exercise program (%)* 16 21 21 14 9  0.001
*Missing cases exist.
BMI  body mass index; CHF  congestive heart failure; LAD  left anterior descending coronary artery; MI  myocardial infarction.
Table 2. Procedural Characteristics of Study Patients According to BMI
Procedural Characteristic
BMI at Baseline (kg/m2)
p Value<20 20–24.9 25–29.9 30–34.9 >35
PTCA group (n  2,108)* n  36 n  505 n  994 n  427 n  146
No. of intended lesions (mean) 2.4 2.6 2.5 2.5 2.5 0.61
No. of attempting lesions (mean) 1.9 2.0 2.0 2.1 2.1 0.82
PTCA of intended lesion, success (%)† 0.24
All intended successful 44 45 48 51 56
Some intended successful 11 12 13 10 9
None intended successful 44 43 39 40 35
CABG group (n  1,526) n  28 n  362 n  683 n  350 n  103
Calcified aorta (%)‡ 4 8 6 6 8 0.69
No. of grafts (mean) 3.1 2.9 2.9 2.9 2.9 0.48
IMA graft used (%) 75 80 87 82 86 0.02
All intended vessels grafted (%) 93 93 91 93 94 0.79
*From the original series of 2,108 PTCA-treated patients, the intended lesion strategy could not be determined in 61 patients. †Lesion success was defined as post-PTCA stenosis
50%, 20% improvement in minimal lumen diameter and Thrombolysis In Myocardial Infarction trial flow grade 3 or 4. ‡There were 26 missing cases.
BMI  body mass index; CABG  coronary artery bypass graft surgery; IMA  internal mammary artery; PTCA  percutaneous transluminal coronary angioplasty.
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In-hospital events. Among patients who had PTCA, the
incidence of a major in-hospital event (death, MI, stroke or
coma) was highest (5.6%) among the very lean (BMI
20 kg/m2), lowest (2.1%) among the severely obese (BMI
35 kg/m2) and intermediate among those not at extremes
of BMI (linear p  0.02) (Table 3). After statistical
adjustment, the inverse association between BMI and major
in-hospital events was marginally attenuated (linear p 
0.07) and suggested a protective effect at higher levels of
BMI. The incidence of an in-hospital cardiopulmonary
event was exceptionally high (27.8%) among the very lean
(BMI 20 kg/m2) and suggested a strong inverse linear
relationship with BMI before (linear p  0.001) and after
(linear p  0.003) statistical adjustment (Table 3). Local
complications were infrequent, but again suggested a lower
adjusted risk at higher levels of BMI. Finally, there was a
strong inverse linear relationship between BMI and the risk
of any in-hospital event before (linear p  0.001) and after
(linear p  0.001) statistical adjustment.
Among patients who had CABG, baseline BMI was
unrelated to the incidence or adjusted risk of in-hospital
major events, cardiopulmonary events, local complications
or any event or complication (Table 4). Moreover, unlike
patients who had PTCA, there was a modest suggestion
that very lean (BMI 20 kg/m2), surgically treated patients
experienced a relatively more favorable in-hospital outcome.
Long-term mortality after initial hospital discharge.
Compared with patients with a normal BMI (20 to
24.9 kg/m2) who had PTCA, the adjusted risk of five-year
mortality after initial hospital discharge was lower (p NS)
among PTCA-treated patients classified as overweight
(BMI 25 to 29.9 kg/m2) or class I obese (BMI 30 to
34.9 kg/m2) (Table 5). When classified by cause of death,
the adjusted risk of five-year cardiac mortality appeared to
be curvilinear with a higher risk of mortality at BMI
extremes; however, this did not attain statistical significance,
perhaps in part due to low statistical power.
Among CABG-treated patients, BMI was positively













Low (20) 36 5.6 1.29 0.87 0.17–4.45 0.87
Normal (20–24.9) 505 4.4 1.0 1.0 — —
Overweight (25–29.9) 994 3.5 0.80 0.74 0.42–1.29 0.29
Class I obesity (30–34.9) 427 2.3 0.53 0.55 0.25–1.20 0.13
Class II/III obesity (35) 146 2.1 0.46 0.58 0.17–2.02 0.39
0.07†
Cardiopulmonary event*
Low (20) 36 27.8 2.61 2.03 0.90–4.60 0.09
Normal (20–24.9) 505 12.9 1.0 1.0 — —
Overweight (25–29.9) 994 8.0 0.59 0.60 0.42–0.85 0.005
Class I obesity (30–34.9) 427 7.5 0.55 0.56 0.35–0.89 0.01
Class II/III obesity (35) 146 8.9 0.66 0.72 0.38–1.39 0.33
0.003‡
Emergency revascularization*
Low (20) 36 2.8 0.87 0.97 0.12–7.78 0.98
Normal (20–24.9) 505 3.2 1.0 1.0 — —
Overweight (25–29.9) 994 1.9 0.60 0.56 0.28–1.12 0.10
Class I obesity (30–34.9) 427 1.4 0.44 0.43 0.16–1.12 0.08
Class II/III obesity (35) 146 3.4 1.08 1.02 0.35–2.93 0.98
0.31‡
Local complications*
Low (20) 36 2.8 1.57 0.53 0.05–5.29 0.59
Normal (20–24.9) 505 1.8 1.0 1.0 — —
Overweight (25–29.9) 994 0.8 0.45 0.54 0.20–1.45 0.22
Class I obesity (30–34.9) 427 0.7 0.39 0.51 0.13–1.94 0.32
Class II/III obesity (35) 146 0.0 0.0 0.0 — —
0.08‡
Any event/complication
Low (20) 36 27.8 1.75 1.37 0.61–3.04 0.44
Normal (20–24.9) 505 18.0 1.0 1.0 — —
Overweight (25–29.9) 994 11.5 0.59 0.60 0.44–0.81 0.01
Class I obesity (30–34.9) 427 9.8 0.50 0.52 0.34–0.77 0.01
Class II/III obesity (35) 146 11.0 0.56 0.63 0.35–1.13 0.12
 0.001‡
*Refer to Methods for definitions. †There were 18 missing cases; all outcomes were adjusted for age, gender, race, treated diabetees, hypertension, congestive heart failure, severe
angina (class III/IV or unstable), peripheral vascular disease, smoking, history of malignancy and renal dysfuction. ‡Linear p value (BMI as continuous variable).
BMI  body mass index.
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associated with the risk of five-year mortality, especially
cardiac mortality, after the initial in-hospital discharge
(Table 6). Indeed, compared with patients with a normal
BMI (20 to 24.9 kg/m2), those with the highest BMI
(35 kg/m2) were estimated to have a nearly fivefold higher
adjusted risk of cardiac mortality. Moreover, the adjusted
risk of cardiac mortality increased monotonically at higher
levels of BMI (linear p  0.001).












Low (20) 28 3.6 0.48 0.47 0.06–3.64 0.47
Normal (20–24.9) 362 7.2 1.0 1.0 — —
Overweight (25–29.9) 683 7.6 1.06 1.01 0.61–1.66 0.98
Class I obesity (30–34.9) 350 6.6 0.91 0.78 0.42–1.44 0.42
Class II/III obesity (35) 103 5.8 0.80 0.67 0.25–1.75 0.41
0.39‡
Cardiopulmonary event*
Low (20) 28 3.6 0.30 0.26 0.03–1.97 0.19
Normal (20–24.9) 362 11.0 1.0 1.0 — —
Overweight (25–29.9) 683 10.2 0.92 1.00 0.65–1.54 0.99
Class I obesity (30–34.9) 350 11.4 1.04 1.03 0.63–1.69 0.91
Class II/III obesity (35) 103 8.7 0.77 0.70 0.30–1.61 0.40
0.90‡
Local complications*
Low (20) 28 3.6 0.75 0.74 0.09–5.83 0.77
Normal (20–24.9) 362 4.7 1.0 1.0 — —
Overweight (25–29.9) 683 3.9 0.84 0.89 0.47–1.68 0.71
Class I obesity (30–34.9) 350 4.6 0.97 0.98 0.46–2.07 0.95
Class II/III obesity (35) 103 1.9 0.40 0.25 0.03–1.97 0.19
0.57‡
Any event/complication
Low (20) 28 10.7 0.50 0.47 0.13–1.62 0.23
Normal (20–24.9) 362 19.3 1.0 1.0 — —
Overweight (25–29.9) 683 17.1 0.86 0.89 0.63–1.25 0.50
Class I obesity (30–34.9) 350 19.1 0.99 0.94 0.63–1.40 0.77
Class II/III obesity (35) 103 14.6 0.71 0.62 0.31–1.20 0.16
0.42‡
*Refer to Methods for definitions. †There were 19 missing cases; all outcomes were adjusted for age, gender, race, treated diabetes, hypertension, congestive heart failure, severe
angina (class III/IV or unstable), peripheral vascular disease, smoking, history of malignancy and renal dysfunction. ‡Linear p value (BMI as continuous variable).
BMI  body mass index.
Table 5. Incidence and Relative Risks of Long-Term Mortality According to BMI: Percutaneous Transluminal Coronary Angioplasty









Interval p Value3 years 5 years
All-cause mortality
Low (20) 35 20.0 20.0 2.09 1.49 0.63–3.53 0.36
Normal (20–24.9) 502 6.6 10.8 1.0 1.0 — —
Overweight (25–29.9) 984 4.6 8.5 0.78 0.66 0.46–0.95 0.02
Class I obesity (30–34.9) 424 5.2 9.9 0.92 0.68 0.44–1.04 0.07
Class II/III obesity (35) 145 9.7 12.4 1.18 1.02 0.58–1.79 0.95
0.46‡
Cardiac mortality
Low (20) 35 11.6 11.6 2.64 2.05 0.62–6.76 0.24
Normal (20–24.9) 502 3.4 4.9 1.0 1.0 — —
Overweight (25–29.9) 984 2.4 4.4 0.91 0.73 0.43–1.23 0.24
Class I obesity (30–34.9) 424 3.6 6.0 1.23 0.82 0.45–1.50 0.52
Class II/III obesity (35) 145 6.3 8.5 1.76 1.46 0.70–3.06 0.31
0.59‡
*Excludes the 18 patients who died in the hospital. †There were 69 missing cases; all outcomes were adjusted for age, gender, race, treated diabetes, hypertension, congestive
heart failure; severe angina (class III/IV or unstable), peripheral vascular disease, smoking, history of malignancy, renal dysfunction and involvment in a regular exercise program.
‡Linear p value (BMI as continuous variable).
BMI  body mass index; RR  relative risk.
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DISCUSSION
In this study, we observed a surprising dichotomy between
PTCA- and CABG-treated patients in short- and long-
term outcomes across levels of BMI. Among patients who
had PTCA, each unit increase in BMI was associated with
a 5.5% lower adjusted risk of a major in-hospital event,
whereas among patients who had CABG, no difference in
the in-hospital outcome was observed. In contrast, BMI was
not associated with five-year mortality or cardiac mortality
in PTCA-treated patients, whereas among CABG-treated
patients, each unit increase in BMI was associated with an
11% higher adjusted risk of five-year cardiac mortality.
Possible explanations for the findings. Our findings in
the PTCA group are similar to those in a previous report
(8). Patients classified as overweight or obese had the lowest
risk of an in-hospital major event, cardiopulmonary com-
plications or local complications after PTCA. We postulate
that this improved procedural outcome may be a function of
a larger vessel size and a relatively favorable artery/device
ratio (17). The outcome after PCI is worse in patients with
smaller vessels, and it may be speculated that a smaller BMI
is associated with smaller coronary vessels (18). Further-
more, as the local risk of complications increases with an
increasing sheath size (19), it may well be that the relative
sheath/artery mismatch may contribute to an increased risk
of local complications in lean patients or may have a
protective effect in those with a larger body mass.
In agreement with previous studies (10–12), BMI was
not associated with a short-term outcome among CABG-
treated patients. However, long-term mortality in CABG-
treated patients appears to be strongly influenced by BMI.
The increased risk of mortality at higher levels of BMI is
most likely due, at least in part, to the increased likelihood
of obese patients having multiple coronary risk factors.
Furthermore, obesity is associated with a high rate of
cardiovascular and noncardiovascular morbidity and mortal-
ity, and it is unlikely that coronary revascularization com-
pletely attenuates this increased risk. Finally, the adverse
effect of BMI in CABG-treated patients appears to be
independent of the concomitant risk factors (confounding
variables) associated with BMI.
The variable long-term outcome in the PTCA group, and
its inconsistency with the long-term outcome in the CABG
group, needs to be interpreted with caution. The apparently
comparable (if not higher) long-term survival in the over-
weight and class I obese patients after PCI (as compared
with lean and normal-weight patients) may speculatively be
partly due to delayed protective effects of a favorable
device/artery ratio. Whether this finding reflects a chance
variation rather than a valid result should be explored in
other large series of PCI-treated patients.
Study limitations. The number of patients at the extreme
levels of BMI was small; thus, the apparent worse short-
term outcome in the lean, PCI-treated patients needs
confirmation from other studies. Similarly, statistical power
was limited for groups at the extremes of BMI. In addition,
it is possible that BMI may play a role in the choice of
modality of revascularization. To verify or refute such a
possibility, we analyzed the patients followed in the registry
and did not find an interaction between BMI and the choice
of revascularization modality. Finally, the tools and tech-
niques of PCI have undergone significant change since the
time of BARI, and the increased complication rate observed
in lean patients may not persist today with current inter-
ventional devices and adjunctive platelet glycoprotein IIb/
IIIa inhibitor usage. Hence, our data underscore the need to
study the impact of BMI on the outcome of coronary
revascularization in the current era. If similar results are
observed, then BMI would need to be one of the factors
taken into consideration while choosing the modality of










Interval p Value3 years 5 years
All-cause mortality
Low (20) 27 3.7 7.4 1.19 0.69 0.09–5.19 0.72
Normal (20–24.9) 356 3.9 6.2 1.0 1.0 — —
Overweight (25–29.9) 674 3.3 8.0 1.29 1.49 0.89–2.52 0.13
Class I obesity (30–34.9) 344 4.9 9.9 1.62 1.52 0.85–2.71 0.15
Class II/III obesity (35) 102 7.9 13.8 2.35 1.73 0.79–3.79 0.17
0.04‡
Cardiac mortality
Low (20) 27 0.0 0.0 0.0 0.0 — —
Normal (20–24.9) 356 0.8 1.7 1.0 1.0 — —
Overweight (25–29.9) 674 0.9 2.8 1.58 2.02 0.74–5.53 0.17
Class I obesity (30–34.9) 344 2.6 5.0 2.98 3.16 1.12–8.92 0.03
Class II/III obesity (35) 102 5.0 7.1 4.31 4.85 1.37–17.2 0.01
 0.001‡
*Excludes the 23 patients who died in the hospital. †There were 59 missing cases; all outcomes were adjusted for age, gender, race, treated diabetes, hypertension, congestive
heart failure; severe angina (class III/IV or unstable), peripheral vascular disease, smoking, history of malignancy and renal dysfunction. ‡Linear p value (BMI as continuous
variable).
Abbreviations as in Table 5.
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revascularization (i.e., a case could be made for preferring
CABG over PCI in lean patients, and vice versa for obese
patients).
Conclusions. Body mass index appears to have a differen-
tial impact on short- and long-term outcomes after coronary
revascularization. Although a higher BMI seems to be
associated with a better short-term outcome after PCI, BMI
does not significantly impact the early outcome after
CABG. In contrast, an increased BMI is associated with a
worse long-term outcome after CABG, but not after PCI.
Our findings underscore the need for further research to
determine the factors that may be responsible for the
apparent short-term protective effect of a higher BMI in
patients undergoing PCI and to study the impact of weight
reduction on the long-term survival of obese patients
undergoing coronary revascularization.
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